Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘antiplatelet’

March 22, 2021 · Leave a Comment

Mayo Clinic Research in the news — 3/22/2021

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

News including Mayo Clinic research and research expertise this week covered a wide range of topics, including genetic testing to inform prescribing blood thinners and therapies for bile duct and gall bladder cancers. A number of women’s health related articles highlighted Mayo Clinic research, there were some arguments for naps, and the ever present COVID-19 […]

View full entry Comment on this

Tags: antiplatelet, asthma, bile duct cancer, breast cancer, COVID-19, Diego Zaquera Carvalho, Elizabeth Stewart, gall bladder cancer, gastroenterology, genetic testing, genetics, genomics


September 3, 2020 · Leave a Comment

Largest pharmacogenetics clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in cardiology, suggests that genetic testing could […]

View full entry Comment on this

Tags: antiplatelet, cardiology, Center for Individualized Medicine, Charanjit Rihal, clinical trials, coronary artery disease, gene varient, genetics, heart disease, Kent Bailey, Michael Farkouh, Naveen Pereira


August 5, 2019 · Leave a Comment

Blood thinners in combination increase bleeding risk, Mayo study finds

By Adam Harringa Adam Harringa (@harringaadam)

Gastrointestinal bleeding is a common side effect for many blood-thinning medications. But new Mayo Clinic research finds that risk is amplified when patients receive more than one blood thinner – especially if they’re 75 or older. The study, published in Clinical Gastroenterology and Hepatology, found patients receiving an anticoagulant drug and an antiplatelet drug, in […]

View full entry Comment on this

Tags: AHRQ, anticoagulant, antiplatelet, blood thinner, Center for the Science of Health Care Delivery, Che Ngufor, gastroenterology, Neena Abraham, Nilay Shah, OptumLabs, Peter Noseworthy, Xiaoxi Yao


Contact Us · Privacy Policy